| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 499 | 1.375 | 0 |
| Total Income - EUR | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 499 | 1.375 | 0 |
| Total Expenses - EUR | 917 | 766 | 0 | 699 | 369 | 984 | 53 | 321 | 643 | 493 |
| Gross Profit/Loss - EUR | -917 | -766 | 0 | -699 | -369 | -984 | -53 | 179 | 732 | -493 |
| Net Profit/Loss - EUR | -917 | -766 | 0 | -699 | -369 | -984 | -53 | 164 | 615 | -493 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Exosyphen Development Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | -15 | -63 | -62 | -60 | -60 | -63 | -58 | -52 | 1 | 20 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | -73 | -73 | -71 | -70 | -69 | -67 | -66 | -66 | 0 | 14 |
| Cash | 59 | 9 | 9 | 10 | 8 | 4 | 8 | 14 | 1 | 6 |
| Shareholders Funds | -1.972 | -2.718 | -2.672 | -4.083 | -4.373 | -5.274 | -5.210 | -5.063 | -4.432 | -4.900 |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 207 | 202 | 203 | 202 | 201 |
| Debts | 1.957 | 2.654 | 2.609 | 4.023 | 4.313 | 5.211 | 5.152 | 5.010 | 4.433 | 4.920 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "6201 - 6201" | |||||||||
| CAEN Financial Year |
6201
|
|||||||||
Comments - Exosyphen Development Srl